Literature DB >> 17898065

Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells.

Borbala Gerle1, Anita Koroknai, György Fejer, Agnes Bakos, Ferenc Banati, Kalman Szenthe, Hans Wolf, Hans Helmut Niller, Janos Minarovits, Daniel Salamon.   

Abstract

We analyzed the levels of acetylated histones and histone H3 dimethylated on lysine 4 (H3K4me2) at the LMP2A promoter (LMP2Ap) of Epstein-Barr virus in well-characterized type I and type III lymphoid cell line pairs and additionally in the nasopharyngeal carcinoma cell line C666-1 by using chromatin immunoprecipitation. We found that enhanced levels of acetylated histones marked the upregulated LMP2Ap in lymphoid cells. In contrast, in C666-1 cells, the highly DNA-methylated, inactive LMP2Ap was also enriched in acetylated histones and H3K4me2. Our results suggest that the combinatorial effects of DNA methylation, histone acetylation, and H3K4me2 modulate the activity of LMP2Ap.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17898065      PMCID: PMC2169097          DOI: 10.1128/JVI.01396-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  A role for SKIP in EBNA2 activation of CBF1-repressed promoters.

Authors:  S Zhou; M Fujimuro; J J Hsieh; L Chen; S D Hayward
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  DNA methyltransferase Dnmt1 associates with histone deacetylase activity.

Authors:  F Fuks; W A Burgers; A Brehm; L Hughes-Davies; T Kouzarides
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

3.  Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus.

Authors:  D Salamon; M Takacs; D Ujvari; J Uhlig; H Wolf; J Minarovits; H H Niller
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Epigenetics of latent Epstein-Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes.

Authors:  M Takacs; D Salamon; S Myöhänen; H Li; J Segesdi; D Ujvari; J Uhlig; H H Niller; H Wolf; G Berencsi; J Minarovits
Journal:  Biol Chem       Date:  2001-04       Impact factor: 3.915

5.  Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin.

Authors:  Nathalie Alazard; Henri Gruffat; Edwige Hiriart; Alain Sergeant; Evelyne Manet
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

6.  Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus.

Authors:  Charles M Chau; Paul M Lieberman
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.

Authors:  L J Strobl; H Höfelmayr; G Marschall; M Brielmeier; G W Bornkamm; U Zimber-Strobl
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes.

Authors:  Daniel Salamon; Maria Takacs; Fritz Schwarzmann; Hans Wolf; Janos Minarovits; Hans Helmut Niller
Journal:  Virus Genes       Date:  2003-08       Impact factor: 2.332

9.  The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication.

Authors:  György Fejér; Maria M Medveczky; Elizabeth Horvath; Brian Lane; Yuan Chang; Peter G Medveczky
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

10.  The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.

Authors:  U Zimber-Strobl; E Kremmer; F Grässer; G Marschall; G Laux; G W Bornkamm
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

View more
  7 in total

Review 1.  Environmental epigenetics and its implication on disease risk and health outcomes.

Authors:  Shuk-Mei Ho; Abby Johnson; Pheruza Tarapore; Vinothini Janakiram; Xiang Zhang; Yuet-Kin Leung
Journal:  ILAR J       Date:  2012

2.  Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.

Authors:  Liangru Ke; Hufeng Zhou; Chong Wang; Geng Xiong; Yanqun Xiang; Yihong Ling; Abdelmajid Khabir; George S Tsao; Yixin Zeng; Musheng Zeng; Pierre Busson; Elliott Kieff; Xiang Guo; Bo Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-22       Impact factor: 11.205

3.  The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas.

Authors:  Maria Takacs; Judit Segesdi; Ferenc Banati; Anita Koroknai; Hans Wolf; Hans Helmut Niller; Janos Minarovits
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-11-15       Impact factor: 2.576

Review 4.  Epigenetic regulation of EBV persistence and oncogenesis.

Authors:  Italo Tempera; Paul M Lieberman
Journal:  Semin Cancer Biol       Date:  2014-01-24       Impact factor: 15.707

5.  Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22.

Authors:  Raymond Wai-Ming Lung; Joanna Hung-Man Tong; Ying-Man Sung; Pak-Sing Leung; David Chi-Heng Ng; Shuk-Ling Chau; Anthony Wing-Hung Chan; Enders Kai-On Ng; Kwok-Wai Lo; Ka-Fai To
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

Review 6.  Role of chromatin during herpesvirus infections.

Authors:  Sebla B Kutluay; Steven J Triezenberg
Journal:  Biochim Biophys Acta       Date:  2009-03-31

7.  Epigenetic mechanisms in virus-induced tumorigenesis.

Authors:  Elzbieta Poreba; Justyna Karolina Broniarczyk; Anna Gozdzicka-Jozefiak
Journal:  Clin Epigenetics       Date:  2011-03-23       Impact factor: 6.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.